Chargement en cours...
Investigating the potential antiviral activity drugs against SARS-CoV-2 by molecular docking simulation
Recently, scary viral pneumonia is known as (COVID-19) has swept the whole world. The new virus strain designated as SARS-CoV-2 belonging to the coronavirus family. Although the current medical research directed towards the development of a novel therapeutic agent, no anti-viral drug approved until...
Enregistré dans:
| Publié dans: | J Mol Liq |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier B.V.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7399655/ https://ncbi.nlm.nih.gov/pubmed/32839634 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molliq.2020.113968 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|